Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2

被引:0
|
作者
C Abad
M F González-Escribano
L M Diaz-Gallo
J M Lucena-Soto
J L Márquez
E Leo
C Crivell
M Gómez-García
J Martín
A Núñez-Roldán
J R García-Lozano
机构
[1] Servicio de Inmunología,
[2] Instituto de Biomedicina,undefined
[3] Hospital Universitario Virgen del Rocío,undefined
[4] Servicio de Aparato Digestivo,undefined
[5] Hospital Universitario Virgen del Rocío,undefined
[6] Unidad de Enfermedad Inflamatoria Intestinal,undefined
[7] Hospital Universitario Virgen de las Nieves,undefined
[8] Instituto de Parasitología y Biomedicina ‘López Neyra’,undefined
[9] CSIC,undefined
来源
Genes & Immunity | 2011年 / 12卷
关键词
genetic association; Crohn's disease; Toll-like receptors; gene; NOD2/CARD15 gene; gene–gene interactions;
D O I
暂无
中图分类号
学科分类号
摘要
Impaired innate inflammatory response has a key role in the Crohn's disease (CD) pathogenesis. The aim of this study was to investigate the possible role of the TLR10–TLR1–TLR6 gene cluster in CD susceptibility. A total of 508 CD patients (284, cohort 1 and 224, cohort 2) and 576 controls were included. TLR10–TLR1–TLR6 cluster single-nucleotide polymorphisms genotyping, NOD2 mutations and TLR10 mRNA quantification were performed using TaqMan assays. Nucleotide-binding oligomerization domain containing 2 (NOD2) and Toll-like receptor (TLR) loci interaction was analyzed by logistic regression and multifactor-dimensionality reduction (MDR). Entropy-based analysis was used to interpret combination effects. One TLR10 haplotype (TLR10GGGG) was found associated with CD susceptibility in both cohorts, individuals with two copies had approximately twofold more risk of CD susceptibility than individuals having no copies (odds ratio=1.89, P-value=0.0002). No differences in the mRNA levels were observed among the genotypes. The strongest model for predicting CD risk according to the MDR analysis was a two-locus model including NOD2 mutations and TLR10GGGG haplotype (Pc<0.0001). The interaction gain attributed to the combination of both genes was negative (IG=−2.36%), indicating redundancy or independent effects. Our results support association of the TLR10 gene with CD susceptibility. The effect of TLR10 would be independent of NOD2, suggesting different signaling pathways for both genes.
引用
收藏
页码:635 / 642
页数:7
相关论文
共 50 条
  • [1] Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2
    Abad, C.
    Gonzalez-Escribano, M. F.
    Diaz-Gallo, L. M.
    Lucena-Soto, J. M.
    Marquez, J. L.
    Leo, E.
    Crivell, C.
    Gomez-Garcia, M.
    Martin, J.
    Nunez-Roldan, A.
    Garcia-Lozano, J. R.
    GENES AND IMMUNITY, 2011, 12 (08) : 635 - 642
  • [2] Crohn's disease - NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease
    Watanabe, T
    Kitani, A
    Strober, W
    GUT, 2005, 54 (11) : 1515 - 1518
  • [3] Amplification of Toll-like receptor sensitivity by muramyl dipeptide is impaired in Crohn's disease associated NOD2 mutations
    van Heel, DA
    Ghosh, S
    Butler, M
    Hunt, KA
    Lundberg, A
    Ahmad, T
    McGovern, DPB
    Onnie, C
    Negoro, K
    Goldthorpe, S
    Foxwell, BMJ
    Mathew, CG
    Forbes, A
    Jewell, DP
    Playford, RJ
    GUT, 2005, 54 : A1 - A1
  • [4] Epistasis Between Toll-Like Receptor-9 Polymorphisms and Variants in NOD2 and IL23R Modulates Susceptibility to Crohn's Disease
    Toeroek, Helga P.
    Glas, Juergen
    Endres, Ilona
    Tonenchi, Laurian
    Teshome, Molla Y.
    Wetzke, Martin
    Klein, Wolfram
    Lohse, Peter
    Ochsenkuehn, Omas
    Folwaczny, Matthias
    Goeke, Burkhard
    Folwaczny, Christian
    Mueller-Myhsok, Bertram
    Brand, Stephan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (07): : 1723 - 1733
  • [5] Role of Nod2 in the response of macrophages to Toll-like receptor agonists
    Pauleau, AL
    Murray, PJ
    MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (21) : 7531 - 7539
  • [6] Murarnyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease
    van Heel, DA
    Ghosh, S
    Butler, M
    Hunt, KA
    Lundberg, AMC
    Ahmad, T
    McGovern, DPB
    Onnie, C
    Negoro, K
    Goldthorpe, S
    Foxwell, BMJ
    Mathew, CG
    Forbes, A
    Jewell, DP
    Playford, RJ
    LANCET, 2005, 365 (9473): : 1794 - 1796
  • [7] Role of Nod2 in the response of macrophages to toll-like receptor agonists
    Desreumaux, P
    Malapel, M
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2003, 28 (03): : 319 - 320
  • [8] CARD15/NOD2, CD14 and Toll-like 4 Receptor Gene Polymorphisms in Saudi Patients with Crohn's Disease
    Azzam, Nahla
    Nounou, Howaida
    Alharbi, Othman
    Aljebreen, Abedulrahman
    Shalaby, Manal
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (04) : 4268 - 4280
  • [9] Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: Phenotype-genotype correlations
    Peter Laszlo Lakatos
    Laszlo Lakatos
    Ferenc Szalay
    Claudia Willheim-Polli
    Christoph (O|¨)sterreicher
    Zsolt Tulassay
    Tamas Molnar
    Walter Reinisch
    Janos Papp
    Gyula Mozsik
    Hungarian IBD Study Group
    Peter Ferenci
    World Journal of Gastroenterology, 2005, (10) : 1489 - 1495
  • [10] Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: Phenotype-genotype correlations
    Lakatos, Peter Laszlo
    Lakatos, Laszlo
    Szalay, Ferenc
    Willheim-Polli, Claudia
    Oesterreicher, Christoph
    Tulassay, Zsolt
    Molnar, Tamas
    Reinisch, Walter
    Papp, Janos
    Mozsik, Gyula
    Ferenci, Peter
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (10) : 1489 - 1495